COGT
Price
$12.62
Change
+$0.20 (+1.61%)
Updated
Sep 16, 11:05 AM (EDT)
Capitalization
1.73B
62 days until earnings call
INBX
Price
$27.18
Change
-$0.34 (-1.24%)
Updated
Sep 15 closing price
Capitalization
393.79M
58 days until earnings call
Interact to see
Advertisement

COGT vs INBX

Header iconCOGT vs INBX Comparison
Open Charts COGT vs INBXBanner chart's image
Cogent Biosciences
Price$12.62
Change+$0.20 (+1.61%)
Volume$200
Capitalization1.73B
Inhibrx Biosciences
Price$27.18
Change-$0.34 (-1.24%)
Volume$80.62K
Capitalization393.79M
COGT vs INBX Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. INBX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and INBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (COGT: $12.41 vs. INBX: $27.18)
Brand notoriety: COGT and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 49% vs. INBX: 78%
Market capitalization -- COGT: $1.73B vs. INBX: $393.79M
COGT [@Biotechnology] is valued at $1.73B. INBX’s [@Biotechnology] market capitalization is $393.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 1 green, 4 red.
According to our system of comparison, INBX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while INBX’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 5 bearish.
  • INBX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both COGT and INBX are a bad buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а -2.13% price change this week, while INBX (@Biotechnology) price change was -6.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.30%. For the same industry, the average monthly price growth was +6.89%, and the average quarterly price growth was +34.54%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

INBX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+3.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.73B) has a higher market cap than INBX($394M). INBX YTD gains are higher at: 76.526 vs. COGT (59.103). INBX has higher annual earnings (EBITDA): -155.08M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. INBX (187M). COGT has less debt than INBX: COGT (60.7M) vs INBX (107M). INBX has higher revenues than COGT: INBX (1.4M) vs COGT (0).
COGTINBXCOGT / INBX
Capitalization1.73B394M440%
EBITDA-299.34M-155.08M193%
Gain YTD59.10376.52677%
P/E RatioN/A0.20-
Revenue01.4M-
Total Cash238M187M127%
Total Debt60.7M107M57%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTINBX
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THCVX28.30N/A
N/A
Nuveen Large Cap Value Idx I
MPGAX11.82N/A
N/A
MassMutual Disciplined Gr A
AVURX8.45N/A
N/A
American Century Value R
CFVLX34.84N/A
N/A
Commerce Value
CGRNX32.56N/A
N/A
Invesco Comstock Select R

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-1.22%
AXON - INBX
48%
Loosely correlated
+0.62%
AKESF - INBX
45%
Loosely correlated
+1.03%
COGT - INBX
42%
Loosely correlated
-1.97%
ACET - INBX
40%
Loosely correlated
-1.07%
SNTI - INBX
39%
Loosely correlated
+0.74%
More